TCI reports consolidated revenue of ₹13,979 Mn, up 14.8% YoY, and EBITDA of ₹1,759 Mn, an 8.3% increase for Q2 FY2027.
Onesource Specialty Pharma Limited (NSE: ONESOURCE) announces Q2FY27 results with revenue up 37% YoY and EBITDA up 53% YoY.
Astec LifeSciences Limited (ASTEC) reports Q2 FY27 results with a revenue decline and negative EBITDA due to adverse weather and geopolitical uncertainties.
Lumax Industries Limited (LUMAXIND) reports 33% revenue growth and 46% PAT increase in Q2FY27, showcasing strong financial performance.
Aequs Limited (AEQUS) reports a 50% YoY revenue growth in Q2 & H1 FY27, driven by strong performance in the Aerospace segment.
Bank of Maharashtra reports a 41% increase in net profit and a 22% rise in revenue for Q2 FY27, showcasing strong financial performance.
Mankind Pharma Limited (NSE: MANKIND) reports strong financial results with revenue up 17%, EBITDA up 27%, and PAT up 38% for Q2 FY27.
Sakar Healthcare Limited (SAKAR) reports strong Q2 FY27 results with revenue growth of 53% and EBITDA growth of 114% YoY.
Modis Navnirman Limited (MODIS) reports a 53% revenue increase and a 59% rise in PAT for Q2 & H1 FY27, showcasing strong growth in Mumbai's premium...
Central Mine Planning & Design Institute Limited (CMPDI) announces impressive financial results for the first half of FY 2026-27, with a 24% increase in PAT.